A revolutionary new treatment for breast cancer has shown the ability to eliminate small breast tumors and significantly ...

The typical treatment for estrogen receptor positive (ER+) breast cancer involves surgery and years of hormone therapy that ...

Learn how early developmental patterns can influence your lifetime cancer risk and the type of cancer that may develop.

Despite significant therapeutic advances, breast cancer remains a leading cause of cancer-related death in women. Treatment ...

A person's lifetime risk for cancer may begin before they are even born, reports a paradigm-shifting study by Van Andel Institute scientists.

Now, researchers reporting in ACS Central Science have created a novel treatment that eliminated small breast tumors and significantly shrank large tumors in mice in a single dose, without problematic ...

“It is very rare for a compound to shrink tumors in mouse models of breast cancer, let alone completely eradicate those tumors with a single dose, so we are eager for ErSO-TFPy to advance for ...

A little-known mouse protein disrupts cancer-causing chemical changes to genes associated with human colorectal cancer cells and potentially could be used to treat solid tumors, according to a new ...

However, a new drug candidate could hold the potential to eliminate the need for such a grueling process, after a study in mice found that it wiped out a range of breast tumors in a single dose.

Nanovaccine achieved tumour inhibition rate of 89.3 per cent when tested on mice with aggressive form of the disease, study finds.